ID: ALA4090889

Max Phase: Preclinical

Molecular Formula: C13H12N4O

Molecular Weight: 240.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1cccc2c(-c3ccnc(N)n3)c[nH]c12

Standard InChI:  InChI=1S/C13H12N4O/c1-18-11-4-2-3-8-9(7-16-12(8)11)10-5-6-15-13(14)17-10/h2-7,16H,1H3,(H2,14,15,17)

Standard InChI Key:  PPXXYXMSXHLWHA-UHFFFAOYSA-N

Associated Targets(Human)

Glycogen synthase kinase-3 beta 11785 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Dual-specificity tyrosine-phosphorylation regulated kinase 1A 6484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Nuclear factor of activated T-cells cytoplasmic 1 86 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 240.27Molecular Weight (Monoisotopic): 240.1011AlogP: 2.22#Rotatable Bonds: 2
Polar Surface Area: 76.82Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.86CX Basic pKa: 3.83CX LogP: 1.87CX LogD: 1.87
Aromatic Rings: 3Heavy Atoms: 18QED Weighted: 0.72Np Likeness Score: -0.35

References

1. Shaw SJ, Goff DA, Lin N, Singh R, Li W, McLaughlin J, Baltgalvis KA, Payan DG, Kinsella TM..  (2017)  Developing DYRK inhibitors derived from the meridianins as a means of increasing levels of NFAT in the nucleus.,  27  (11): [PMID:28408219] [10.1016/j.bmcl.2017.03.037]

Source